SCHEMBL370558

SCHEMBL370558

Cc1nc(Nc2nc(-c3cn[nH]c3)c(C)s2)ncc1F

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 6/20 0.66
GRM8 O00222 1/20 0.66
APEX1 P27695 1/20 0.35
ALDH1A1 P00352 3/20 0.34
PKM P14618 1/20 0.34
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
DHODH Q02127 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALOX5 P09917 1/20 0.31
MAPK8 P45983 1/20 0.31
LCK P06239 1/20 0.31
MAPK14 Q16539 1/20 0.31
CCNT1 O60563 2/20 0.31
CDK1 P06493 2/20 0.31
CCNB1 P14635 2/20 0.31
CCNA2 P20248 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL368070 0.86 GRM4 (0.67) GRM4GRM8APEX1ALDH1A1PKM
SCHEMBL370185 0.84 GRM4 (0.70) GRM4GRM8ALDH1A1PKMGAA
SCHEMBL370278 0.81 GRM4 (0.77) GRM4GRM8APEX1ALDH1A1MAPT
SCHEMBL369060 0.80 GRM4 (1.00) GRM4GRM8ALDH1A1PKMGAA
SCHEMBL369689 0.79 GRM4 (0.53) GRM4GRM8APEX1ALDH1A1GAA
SCHEMBL370358 0.78 GRM4 (0.56) GRM4GRM8APEX1ALDH1A1PKM
SCHEMBL12482619 0.77 GRM4 (0.66) GRM4GRM8ALDH1A1PKMGAA
SCHEMBL369009 0.77 GRM4 (0.67) GRM4GRM8APEX1ALDH1A1PKM
SCHEMBL370801 0.76 GRM4 (0.69) GRM4GRM8APEX1ALDH1A1PKM
SCHEMBL15166648 0.76 GRM4 (0.63) GRM4GRM8APEX1ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073907-B2 Thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors ADDEX PHARMA S.A. (CH) 2015-07-07 US claimed
EP-2376486-B1 NOVEL THIAZOLES DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMACEUTICALS SA (CH) 2013-11-06 EP claimed
US-20110257179-A1 NOVEL THIAZOLES DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA SA (CH) 2011-10-20 US claimed
US-20110257179-A1 NOVEL THIAZOLES DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA SA (CH) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257179-A1 NOVEL THIAZOLES DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM4, GRM2, GRM1 GRM4 1/4885GRM8 21/4885APEX1 4483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.